Aaron Sato | Chief Strategy Officer
Adimab
Aaron is the Chief Strategy Officer at Adimab, with over 25 years of experience in biotechnology, focusing on discovering and developing novel first-in-class antibody therapeutics. Before joining Adimab, Aaron served as the Chief Scientific Officer of Twist Bioscience, where he led their Biopharma Solutions business. Prior to Twist, he served as Chief Scientific Officer of LakePharma, leading the California Antibody Center. He is the author of over 40 peer-reviewed papers and 60 issued patents in the antibody space.
Appearances:
Festival of Biologics Day 1 @ 15:20
Human Antibody Discovery and Engineering: The Adimab Way
This presentation will explore how Adimab has revolutionized therapeutic antibody discovery, growing from an innovative startup into a leading platform technology company. We will examine key technological breakthroughs in our platform development, focusing on synthetic antibody library evolution, advances in multispecific antibody generation, and novel approaches to antibody developability optimization. Through specific examples, we will demonstrate how our engineering solutions have enhanced therapeutic candidates and improved their potential for success. Join us to learn how Adimab's systematic, engineering-driven approach is shaping the future of antibody therapeutics.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events